WHO. Hepatitis B, Fact sheets n.d. (2022) https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 9 October 2024

Schillie S, Murphy V, Sawyer M et al (2013) Centers for Disease Control and Prevention (CDC). CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 62:1–19

PubMed  Google Scholar 

Schillie S, Vellozzi C, Reingold A et al (2018) Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 67:1–31. https://doi.org/10.15585/mmwr.rr6701a1

Article  PubMed  PubMed Central  Google Scholar 

Cui FQ, Wang XJ, Cao L et al (2007) Progress in hepatitis B prevention through universal infant vaccination–China, 1997–2006. MMWR Morb Mortal Wkly Rep 11:441–445

Google Scholar 

Republic of Turkey Ministry of Health (2018) Türkiye viral hepatitis prevention and control program. 2018–2023 [Internet] 7

Tozun N, Ozdogan O, Cakaloglu Y et al (2015) Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 21:1020–1026. https://doi.org/10.1016/j.cmi.2015.06.028

Article  PubMed  Google Scholar 

Chiara F, Bartolucci GB, Mongillo M et al (2013) Hepatitis B vaccination at three months of age: a successful strategy? Vaccine 31:1696–1700. https://doi.org/10.1016/j.vaccine.2013.01.046

Article  PubMed  Google Scholar 

Li H, Li GJ, Chen QY et al (2017) Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed? Epidemiol Infect 145:887–894. https://doi.org/10.1017/S0950268816003046

Article  PubMed  PubMed Central  Google Scholar 

Bruce MG, Bruden D, Hurlburt D et al (2016) Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis 214:16–22

Article  PubMed  Google Scholar 

Bruce MG, Bruden D, Hurlburt D et al (2022) Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology 76:1180–1189. https://doi.org/10.1002/hep.32474

Article  PubMed  Google Scholar 

Banatvala J, Van Damme P, Oehen S (2000) Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 19:877–885

Article  PubMed  Google Scholar 

Schweitzer A, Horn J, Mikolajczyk RT et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555. https://doi.org/10.1016/S0140-6736(15)61412-X

Article  PubMed  Google Scholar 

Publication WHO (2019) Hepatitis B vaccines: WHO position paper, July 2017–Recommendations. Vaccine 37:223–225. https://doi.org/10.1016/j.vaccine.2017.07.046

Article  Google Scholar 

Conner EE, Panagiotakopoulos L, Hofmeister MG et al (2023) Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR Morb Mortal Wkly Rep 72:1–25

Google Scholar 

Terrault NA, Lok ASF, McMahon BJ et al (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560–1599. https://doi.org/10.1002/hep.29800

Article  PubMed  Google Scholar 

Vogel RM (2022) The geometric mean? Commun Stat Theorm 51:82–94

Article  Google Scholar 

Zhao YL, Han BH, Zhang XJ et al (2019) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infect Dis 19:1–7. https://doi.org/10.1186/s12879-019-4134-9

Article  Google Scholar 

Dumaidi K, Al-Jawabreh A (2015) Persistence of anti-HBs among Palestinian medical students after 18–22 years of vaccination: a cross-sectional study. Hepat Mon 15:e29325. https://doi.org/10.5812/hepatmon.29325

Article  PubMed  PubMed Central  Google Scholar 

Ma JC, Wu ZW, Zhou HS et al (2020) Long-term protection at 20–31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community. Hum Vaccin Immunother 16:16–20. https://doi.org/10.1080/21645515.2019.1646575

Article  PubMed  Google Scholar 

Wang F, Shen L, Cui F et al (2015) The long-term efficacy, 13–23 years, of a plasmaderived hepatitis B vaccine in highly endemic areas in China. Vaccine 33:2704–2709. https://doi.org/10.1016/j.vaccine.2015.03.064

Article  PubMed  Google Scholar 

Lamberti M, De Rosa A, Garzillo EM et al (2015) Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme? J Occup Med Toxicol 10:1–6. https://doi.org/10.1186/s12995-015-0083-4

Article  Google Scholar 

Publication WHO (2010) Hepatitis B vaccines: WHO position paper recommendations. Vaccine 28:589–590. https://doi.org/10.1016/j.vaccine.2009.10.110

Article  Google Scholar 

Zimmermann P, Curtis N (2019) Factors that influence the immune response to vaccination. Clin Microbiol Rev 32:10–1128

Article  Google Scholar 

Young KM, Gray CM, Bekker LG (2013) Is obesity a risk factor for vaccine non-responsiveness? PLoS ONE 12:e82779. https://doi.org/10.1371/journal.pone.0082779

Article  Google Scholar 

Hv T, Bock CT, Velavan TP (2014) Genetic insights on host and hepatitis B virus in liver diseases. Mutat Res Rev Mutat Res 762:65–75. https://doi.org/10.1016/j.mrrev.2014.06.001

Article  Google Scholar 

Tajiri K, Shimizu Y (2015) Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol 21:7074–7083. https://doi.org/10.3748/wjg.v21.i23.7074

Article  PubMed  PubMed Central  Google Scholar 

Moulton VR (2018) Sex hormones in acquired immunity and autoimmune disease. Front Immunol 4:2279. https://doi.org/10.3389/fimmu.2018.02279

Article  Google Scholar 

Sánchez PS, García RV, Haquet MVL et al (2024) Hormones and B-cell development in health and autoimmunity. Front Immunol 12:1385501. https://doi.org/10.3389/fimmu.2024.1385501

Article  Google Scholar 

Siegrist CA, Aspinall R (2009) B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 9:185–194. https://doi.org/10.1038/nri2508

Article  PubMed  Google Scholar 

Bianchi FP, Gallone MS, Gallone MF et al (2019) HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: an Italian study among medical students. J Viral Hepat 26:136–144. https://doi.org/10.1111/jvh.13001

Article  PubMed  Google Scholar